Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263614
Status:
COMPLETED
Last Update Posted:
2009-02-03
First Post:
2005-12-08
Brief Title:
Evaluation of Chronic HBV Patients wEvidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Study Overview
Official Title:
A Cross Sectional and Retrospective Evaluation in HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B CHBPatients With Evidence of HBV Replication and Normal or Minimally Elevated Liver TransaminasesThe MELT Study
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine whether HBeAg-positive and HBeAg-negative patients with HBV DNA greater than or less than 5 log10 and 4 log10 copiesmL respectively and with normal or minimally elevated liver transaminases have histological evidence of active liver disease
Detailed Description:
To determine whether HBeAg-positive and HBeAg-negative patients with HBV DNA greater than or less than 5 log10 and 4 log10 copiesmL respectively and with normal or minimally elevated liver transaminases have histological evidence of active liver disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None